Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic
May 19, 2026
Axinn represented Tecomet, together with its sponsor Charlesbank, as antitrust counsel in Tecomet’s combination with Orchid Orthopedic Solutions, forming a scaled global manufacturing partner serving MedTech and Aerospace & Defense customers. The transaction closed on May 14, 2026.
The Axinn team was led by partners John Harkrider and Craig Minerva and included partner James Hunsberger, counsel Carol Xianxiao Liu and Monica Smith, and associates John Bogert, Quinten Stewart, Kaitlin Rittgers, and Robert Walmsley.
More details can be found here.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CWCC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
Benchmark Litigation Honors Axinn Partners on 2026 “40 & Under List”
Awards & Recognitions
Litigation & Trials
Axinn Partner Rebecca Clegg Named to Hartford Business Journal’s 2026 40 Under Forty
Awards & Recognitions
Intellectual Property